Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
Harvard Business School
Chinese Patent Office
Cerilliant
Cipla
Deloitte
Covington
Johnson and Johnson

Generated: April 20, 2018

DrugPatentWatch Database Preview

VISKEN Drug Profile

« Back to Dashboard

Which patents cover Visken, and what generic alternatives are available?

Visken is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VISKEN is pindolol. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pindolol profile page.
Drug patent expirations by year for VISKEN
Synonyms for VISKEN
(.+/-.)-Pindolol
(+-)-4-(2-hydroxy-3-(isopropylamino)propoxy)indole
(+-)-lb46
(+-)-Pindolol
(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol
(R,S)-PINDOLOL
(rs)-pindolol
[2-hydroxy-3-(1H-indol-4-yloxy)propyl](propan-2-yl)amine
1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol
1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol
1-(1h-indol-4-yloxy)-3-((1-methylethyl)amino)-2-propano
1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #
1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol
1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol
1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol)
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol)
1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol
1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol
1-[1H-INDOL-4-YLOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL
13523-86-9
2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-
2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-
2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-
2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-
2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-
2-PROPANOL,1-(1H-INDOL-4-YLOXY)-3-[(1-METHYLETHYL)AMINO]-,()-
21870-06-4
3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol
4-(2-Hydroxy-3-isopropylaminopropoxy)-indole
4-(3-(Isopropylamino)-2-hydroxypropoxy)indole
5-21-03-00017 (Beilstein Handbook Reference)
523P869
AB00052072
AB00052072_12
AB00052072_13
AB00052072-11
AC1L1J1N
AC1Q1QC1
AKOS015969756
AN-18448
API0000920
BDBM50019443
Betapindol
Betapindol (TN)
BG0392
Bio-0642
Blockin L
Blockin L (TN)
Blocklin
Blocklin L
Blocklin L (TN)
Blocklin-L
Blocklin-L (TN)
BPBio1_000022
BRD-A97701745-001-05-3
BRN 1536506
BSPBio_000020
BSPBio_002193
C-15218
C07445
Calvisken
Calvisken (TN)
Carvisken
Carvisken (TN)
CAS-13523-86-9
CC-33796
CCG-39223
CCRIS 9215
CHEBI:8214
CHEMBL500
CPD000059120
CS-4473
CTK8G2432
D00513
D0F2PO
DB00960
Decreten
Decreten (TN)
DivK1c_000837
DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole
DL-LB 46
DL-Pindolol
DSSTox_CID_3476
DSSTox_GSID_23476
DSSTox_RID_77043
DTXSID8023476
Durapindol
Durapindol (TN)
EINECS 236-867-9
EINECS 244-623-8
EU-0100955
FT-0630406
Glauco-visken
Glauco-Visken (TN)
Glauco-Viskin
GTPL91
HE052912
HE115935
HE299989
HE307748
HMS1568A22
HMS1920H16
HMS2089I21
HMS2091P20
HMS2095A22
HMS3259I07
HMS3262P12
HMS3267K17
HMS3369E14
HMS502J19
HSDB 6539
HY-B0982
IDI1_000837
JZQKKSLKJUAGIC-UHFFFAOYSA-N
KBio1_000837
KBio2_001589
KBio2_004157
KBio2_006725
KBio3_001693
KBioGR_000958
KBioSS_001589
L000006
LB 46
LB-46
LB46
Lopac0_000955
LP00955
LS-122385
MCULE-7764948919
MFCD00010530
MLS000069496
MLS002548891
MolPort-001-792-503
NC00467
NCGC00015786-06
NCGC00015786-07
NCGC00015786-08
NCGC00015786-09
NCGC00015786-10
NCGC00015786-11
NCGC00015786-13
NCGC00015786-14
NCGC00015786-16
NCGC00024925-03
NCGC00024925-04
NCGC00024925-05
NCGC00024925-06
NCGC00024925-07
NCGC00261640-01
NINDS_000837
NSC-757276
NSC757276
Oprea1_770884
P 0778
P-6820
PDSP1_000771
PDSP1_000772
PDSP2_000759
PDSP2_000760
Pectobloc
Pectobloc (TN)
Pharmakon1600-01500488
Pinbetol
Pinbetol (TN)
pindolol
Pindolol (JP15/USP/INN)
Pindolol (JP17/USP/INN)
Pindolol [USAN:INN:BAN:JAN]
Pindolol [USAN:USP:INN:BAN:JAN]
Pindolol, >=98% (TLC), powder
Pindolol, European Pharmacopoeia (EP) Reference Standard
Pindolol, United States Pharmacopeia (USP) Reference Standard
PINDOLOL,(-)
Pindololum
Pindololum [INN-Latin]
Prestwick_397
Prestwick0_000090
Prestwick1_000090
Prestwick2_000090
Prestwick3_000090
Prindolol
Prindolol (TN)
Prinodolol
Pynastin
Pynastin (TN)
SAM002264631
SBI-0050929.P004
SC-25688
SCHEMBL5219
SMR000059120
SPBio_001289
SPBio_001959
Spectrum_001109
SPECTRUM1500488
Spectrum2_001285
Spectrum3_000547
Spectrum4_000479
Spectrum5_001266
SR-01000000027
SR-01000000027-2
ST50319990
Tox21_110221
Tox21_110221_1
Tox21_500955
Visken (TN)
Z3376

US Patents and Regulatory Information for VISKEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VISKEN pindolol TABLET;ORAL 018285-001 Sep 3, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis VISKEN pindolol TABLET;ORAL 018285-002 Sep 3, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Queensland Health
Johnson and Johnson
Harvard Business School
Chubb
Colorcon
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.